INGN Inogen Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: INGN

Price (delayed)

$5.06

Market cap

$117.36M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$4.2

Enterprise value

-$28.44M

Inogen is a medical technology company offering innovative respiratory products for use in the homecare setting. Inogen primarily develops, manufactures, and markets innovative portable oxygen concentrators used to deliver supplemental ...

Highlights
The debt has declined by 13% year-on-year and by 3.8% since the previous quarter
The quick ratio has contracted by 13% YoY but it has grown by 3.6% from the previous quarter
The equity has declined by 23% year-on-year and by 2.3% since the previous quarter
Inogen's gross profit has decreased by 18% YoY and by 8% from the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: http://www.inogen.net
Peers: MASI ELMD GTLS RMD

Key stats

What are the main financial stats of INGN
Market
Shares outstanding
23.19M
Market cap
$117.36M
Enterprise value
-$28.44M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.43
Price to sales (P/S)
0.34
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-0.08
Earnings
Revenue
$349.28M
EBIT
-$95.84M
EBITDA
-$75.54M
Free cash flow
-$54.56M
Per share
EPS
-$4.2
Free cash flow per share
-$2.36
Book value per share
$11.88
Revenue per share
$15.09
TBVPS
$14.75
Balance sheet
Total assets
$374.35M
Total liabilities
$99.57M
Debt
$21.88M
Equity
$274.78M
Working capital
$209.86M
Liquidity
Debt to equity
0.08
Current ratio
4.53
Quick ratio
3.73
Net debt/EBITDA
1.93
Margins
EBITDA margin
-21.6%
Gross margin
39.2%
Net margin
-27.6%
Operating margin
-29.3%
Efficiency
Return on assets
-23.6%
Return on equity
-32%
Return on invested capital
-68.5%
Return on capital employed
-30.4%
Return on sales
-27.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

INGN stock price

How has the Inogen stock price performed over time
Intraday
-3.07%
1 week
-1.56%
1 month
-18.12%
1 year
-79.16%
YTD
-74.33%
QTD
-3.07%

Financial performance

How have Inogen's revenue and profit performed over time
Revenue
$349.28M
Gross profit
$137.05M
Operating income
-$102.46M
Net income
-$96.29M
Gross margin
39.2%
Net margin
-27.6%
Inogen's gross profit has decreased by 18% YoY and by 8% from the previous quarter
The gross margin has contracted by 17% YoY and by 3% from the previous quarter
The operating margin has contracted by 15% from the previous quarter
The net margin has declined by 13% since the previous quarter

Growth

What is Inogen's growth rate over time

Valuation

What is Inogen stock price valuation
P/E
N/A
P/B
0.43
P/S
0.34
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-0.08
Inogen's EPS has decreased by 7% from the previous quarter
INGN's P/B is 85% below its 5-year quarterly average of 3.0 and 66% below its last 4 quarters average of 1.3
The equity has declined by 23% year-on-year and by 2.3% since the previous quarter
The stock's price to sales (P/S) is 88% less than its 5-year quarterly average of 2.9 and 68% less than its last 4 quarters average of 1.1
The revenue has declined by 5% since the previous quarter

Efficiency

How efficient is Inogen business performance
Inogen's return on equity has decreased by 14% QoQ
Inogen's ROA has decreased by 13% from the previous quarter
Inogen's ROS has decreased by 13% from the previous quarter
INGN's ROIC is down by 4.7% from the previous quarter

Dividends

What is INGN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for INGN.

Financial health

How did Inogen financials performed over time
INGN's total assets is down by 20% year-on-year and by 2.9% since the previous quarter
The company's current ratio fell by 15% YoY
The debt is 92% smaller than the equity
The equity has declined by 23% year-on-year and by 2.3% since the previous quarter
The debt to equity has increased by 14% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.